StockWatch
·

RAYMOND LTD. Q2 FY27 Results

RAYMONDQ2 FY27 Results
Filing
Result:Good· Market: Down#Base effect#Margin expansion#Margin squeeze

Outlook: Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue655.168.2%24.2%
Total Income683.228.8%21.2%
Expenditure641.229.3%17.8%
PBT42.000.9%128.4%
Net Profit32.063.9%130.8%
OPM11.49%1.27pp35.02pp
NPM4.69%0.22pp2.23pp
EPS3.366.7%96.5%
View full financials

Revenue grew a healthy 24% YoY and adjusted PAT roughly doubled, but the growth is aerospace-segment-led while the larger precision-auto segment's margin missed its own target and consolidated OPM compressed sequentially, with the adjusted PAT comparison also flattered by a depressed year-ago base.

RAYMOND LTD. · Q2 FY-2027 · THE VERDICT

Raymond's Aerospace Engine Runs Strong—But Operating Margins Don't (Yet)

The quarter delivered 24% revenue growth and 27% aerospace expansion, but operating margin has stalled at 11.5% amid freight and commodity headwinds. Management hedged guidance on margin recovery timing. The question: can Andhra facility and cost normalization unlock margin upside, or is this a structural squeeze?

04 Nov 2026 · 6 min read
Revenue

₹655.2 Cr

+24.2% YoY

PAT (reported)

₹32.1 Cr

+130.8% YoY (base-dependent)

OPM

11.5%

flat YoY (freight headwind)

Aerospace growth

27% YoY

₹139 Cr, margin 21%

The quarter delivered everything on the revenue side: 24% growth, aerospace outperforming guidance at 27%, and the Andhra capex project tracking to plan. But there's a gap between the headline growth and what's happening at the profit line. Operating margin has stalled at 11.5%, caught in a vise of freight and raw-material cost inflation that management has not yet cracked. The real story is whether that margin can recover, or whether the company is trapped in a structural squeeze.

The PAT beat is real, but the base is low

Reported PAT of ₹32.1 Cr jumped 130.8% YoY—a headline that catches the eye. But the prior-year base was depressed, making the comparison less informative. The better lens is operating performance: EBITDA margin held at 15.1%, a healthy level, but operating margin contracted to 11.5%, down from historical 13–14% levels. The gap between EBITDA (15.1%) and OPM (11.5%) is the cost of running the Andhra capex program and absorbing freight volatility. Management cited that "key commodity and raw material prices... remained firm at elevated levels, alongside persistent freight and logistics volatility." The company did not commit to a timeline for margin recovery, a notable absence given the revenue strength.

Key commodity and raw material prices, including tool costs, have remained firm at elevated levels, alongside persistent freight and logistics volatility.
Management's key claims—what held up and what was hedged

Aerospace 27% YoY growth; precision 15% YoY

Aerospace ₹139 Cr (+27% YoY); precision ₹471 Cr (+15% YoY)

Supported

EBITDA margin 15.1%; precision segment 13%

EBITDA 103 Cr ÷ 683 Cr total income ≈ 15.1%; precision margin 13%

Supported

Aerospace margin target 25% (mature level)

Q2 delivered 21% (110 bps short); contingent on cost normalization + Andhra scale, no commitment timeline

Hedged—target intact, timeline unclear

High mid-20s aerospace growth guidance (reiterated)

Delivered 27% Q2; management pulled back from 'reiterate 25%' (Q1) to 'high mid-20s' now

Supported but cautious

Andhra greenfield on track for Dec 2027 commercial production

PPAP approvals in parallel with site infrastructure; ₹400 Cr spend by start on schedule

Supported—execution risk remains (PPAP delays)

Aftermarket operationalized Q2 FY27 (per prior guidance)

Confirmed; launched with ~800 part numbers, margin profile 'better than OE'

Supported

What shifted on this call

Three things worth watching: (1) Guidance hedge on aerospace growth: Q1 call reiterated 25% YoY; Q2 call now commits only to 'high mid-20s'—a pullback after delivering 40% Q1 and 27% Q2. Management is managing expectations downward, a prudent but cautious move. (2) Capex plan unchanged: ₹1,000 Cr over 5 years (₹400 Cr aerospace, ₹430 Cr auto) reaffirmed without revision despite inflation. This signals cost discipline or a constrained investment appetite. (3) Margin targets stable but no expansion committed: Aerospace target remains 25% (vs. current 21%), precision 12–13% (at target). No new margin expansion guidance suggests management sees the near-term cost squeeze as real and isn't betting on a quick resolution.

Q2 FY27
09.0318.0727.124.2Revenue growth15.1EBITDA margin11.5OPM
The margin pinch: 24% revenue growth but 11.5% operating margin (down from historical 13–14%), showing that volume growth isn't translating to operating leverage while freight/commodity costs remain elevated.
The bull-bear ledger
  • Aerospace 27% growth outperforms guidance; LEAP market share rising

  • Andhra capex reaffirmed without revision—cost discipline evident

  • Operating margin stalled at 11.5% despite 24% revenue growth—structural squeeze

  • Margin expansion targets hedged; no near-term commitment to 25% aerospace margin

  • Order book opaque (management declined to quantify months/years of backlog)

  • FII ownership down 1.86pp QoQ; stock down 12.44% from ATH—institutional caution

  • Management credibility high (Q1 guidance delivered; track record A-grade)

  • Aftermarket operationalized; new growth leg with margin profile better than OE

Risks, ranked by how much they should concern a holder

Margin compression from freight/commodity inflation unresolved

High

OPM 11.5% vs. historical 13–14% is a 150–250 bps headwind. Pass-through to customers incomplete and contractually lagged. If costs remain sticky through FY27, margin recovery could slip into FY28, capping EPS growth.

Andhra facility execution risk (PPAP approvals, customer sign-offs, construction delays)

Medium

Dec 2027 commercial production start is a hard gate for FY28 margin accretion and capacity targets. Any slip into Q4 FY28 delays revenue/margin benefit by 1–2 quarters and raises capex-to-return questions.

Order book concentration and opacity

Medium

Aerospace revenue concentrated on LEAP engines and 2–3 OEM platforms (Boeing, Airbus). Management refused to quantify backlog (months/years of coverage). Without specific visibility, 'high mid-20s' growth guidance is harder to validate.

Automotive aftermarket scaling unproven

Low

Newly launched (Q2 FY27) with ~800 part numbers. Market fragmented and price-competitive. Smaller contributor relative to aerospace and precision tech; execution risk exists but not material near-term.

How the street is positioned

The post-result price action tells a mixed story. Day 1 saw a -1.95% selloff from the ₹1,081.2 announcement close—a disappointment, likely on muted guidance and no margin expansion commentary. By day 3 the stock had recovered to +1.76%, and by day 5 it had rallied to +8.43%, as the market re-rated the quality of the underlying revenue growth (24% organic, 27% aerospace). But institutional conviction remains tentative: FII ownership fell 186 bps QoQ (from 9.75% to 7.89%), a net sell into the rally. This suggests sophisticated capital is not confident the near-term margin squeeze will ease. The stock sits at ₹1,172.3, above key moving averages (SMA20 ₹1,134.95, SMA50 ₹998.63, SMA200 ₹614.07) but remains 12.44% below its all-time high of ₹1,338.9. The drawdown reflects the market's skepticism: the growth story is intact, but near-term margin recovery and Andhra execution are not assured.

What to watch next (in order of priority)
  • 1 · Operating margin recovery signals (Q3 onwards)

    The core question: do freight/commodity costs begin to normalize or do customer price increases stick? Target to watch: OPM back to 13–14% by H2 FY27 (from current 11.5%). If margin remains stuck or worsens, the aerospace growth story loses leverage.

  • 2 · Andhra facility PPAP approvals and Dec 2027 start confirmation (Q3 FY28)

    Commercial production start is the linchpin for FY28 margin accretion. Any delay (PPAP lag, customer approvals slip, construction snags) into Q4 FY28 pushes revenue/margin benefit out by 1–2 quarters. Watch for management updates on approval timelines and commissioning readiness.

  • 3 · Order book and backlog visibility (Q3–Q4 guidance)

    Management dodged quantifying order book on this call. Next quarter, expect analyst pushback for specific backlog months/years of coverage. Clarity here validates or invalidates the 'high mid-20s' aerospace growth guidance.

Raymond is a quality aerospace franchise executing well on the growth side—27% segment growth, capex discipline, new legs (aftermarket, defense). But operational leverage is proving elusive. Operating margin is stuck at 11.5% despite 24% revenue growth, a structural squeeze from freight and commodity inflation. The path to margin recovery is clear—Andhra facility (Dec 2027), cost normalization, customer price pass-through—but not guaranteed.

For holders: this is not a catalyst trade. It's a steady-execution story gated by Andhra capex, margin recovery (OPM back to 13–14%), and freight/commodity cost abatement. The single number to track from here is operating margin expansion and the timeline to Andhra commercial production. If Dec 2027 slips or costs remain sticky, the stock could re-test the 52-week lows (₹320). If both vectors hit (Andhra Dec on schedule, margin 13%+), upside to the ₹1,338.9 ATH is on the table. Until one of those resolves, the risk/reward is balanced. Hold and monitor Q3 capex/PPAP commentary and quarterly OPM trends.

Informational and educational content only. Not investment advice.